Replies to post #176928 on Biotech Values

[pcrutch]

Re SRPT

How? That's another reason I used strong word because people made these types of assertions without any regard to fact. How could they start ph3 over one year ago when they didn't have any drug available for ph3? Poor planning? Oh right, how terrible for a company almost broken forgot to have scale up manufacture! Maybe it costed money it didn't have at the time!

Agree, at the time SRPT was running on fumes.

However, I do think they have had adequate time and capital to consider providing compassionate use or expand the Ph2 protocol. Been almost 2 years since the Ph2 results and not a single additional patient has been treated.

One behavior that is suspect to me is SRPT's lack of forthrightness about the timing of the FDA meetings and the use of ATMs.